Rick Jackson, Chairman and CEO Jackson Healthcare

“Both, breadth and depth of Bioscience Valuation’s economic assessments as well as the company’s excellent knowledge of healthcare markets are invaluable assets for me in order to reach my goals.”

Prof. Dr. Thomas Danne, Director, and Dr. Bärbel Aschemeier, Clinical Research, AUF DER BULT Hospital for Children and Adolescents

“With the dedicated support, and particularly the experienced, constructive work of Bioscience Valuation, we accomplished highly valuable results that provide important new knowledge enabling our next steps in diabetes research. We sincerely thank the entire Bioscience Valuation team for their valuable and straightforward collaboration in the past year, and look forward to the next opportunity of working with them again.”

Dr. Adi Hoess, CEO Affimed

“Bioscience Valuation’s services help me to communicate the value of our business to various stakeholders, including investors.”

Dr. Folker Ruchatz, SVP Contract Manufacturing Business, Boehringer Ingelheim Biopharmaceuticals GmbH

“I am impressed with Bioscience Valuation’s professional approach that enables us to plan future revenues and capacity utilization much better now.”

Dr. Axel Wiest, COO R&D, Merck-Serono

“I like the insights gained from Bioscience Valuation’s thorough assessments that allow me to support my decisions with well-founded, rational arguments.”